Follow
Lambros T. Koufariotis
Lambros T. Koufariotis
Verified email at qimrberghofer.edu.au
Title
Cited by
Cited by
Year
A catalogue of novel bovine long noncoding RNA across 18 tissues
LT Koufariotis, YPP Chen, A Chamberlain, C Vander Jagt, BJ Hayes
PloS one 10 (10), e0141225, 2015
802015
Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity
F Newell, JS Wilmott, PA Johansson, K Nones, V Addala, ...
Nature communications 11 (1), 1-14, 2020
672020
Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumours
PA Johansson, K Brooks, F Newell, JM Palmer, JS Wilmott, AL Pritchard, ...
Nature communications 11 (1), 1-8, 2020
672020
Regulatory and coding genome regions are enriched for trait associated variants in dairy and beef cattle
L Koufariotis, YPP Chen, S Bolormaa, BJ Hayes
BMC genomics 15 (1), 1-16, 2014
582014
CD155 on tumor cells drives resistance to immunotherapy by inducing the degradation of the activating receptor CD226 in CD8+ T cells
M Braun, AR Aguilera, A Sundarrajan, D Corvino, K Stannard, S Krumeich, ...
Immunity 53 (4), 805-823. e15, 2020
432020
Sequencing the mosaic genome of Brahman cattle identifies historic and recent introgression including polled
L Koufariotis, BJ Hayes, M Kelly, BM Burns, R Lyons, P Stothard, ...
Scientific reports 8 (1), 1-12, 2018
362018
Transcriptome dynamics of CD4+ T cells during malaria maps gradual transit from effector to memory
MSF Soon, HJ Lee, JA Engel, J Straube, BS Thomas, CPS Pernold, ...
Nature Immunology 21 (12), 1597-1610, 2020
252020
DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association
V Lakis, RT Lawlor, F Newell, AM Patch, A Mafficini, A Sadanandam, ...
Communications biology 4 (1), 1-11, 2021
232021
Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance
F Newell, IP da Silva, PA Johansson, AM Menzies, JS Wilmott, V Addala, ...
Cancer Cell 40 (1), 88-102. e7, 2022
222022
Verifying explainability of a deep learning tissue classifier trained on RNA-seq data
M Yap, RL Johnston, H Foley, S MacDonald, O Kondrashova, KA Tran, ...
Scientific reports 11 (1), 1-12, 2021
202021
Non-coding RNAs underlie genetic predisposition to breast cancer
M Moradi Marjaneh, J Beesley, TA O’Mara, P Mukhopadhyay, ...
Genome biology 21 (1), 1-14, 2020
172020
CRISPR/Cas9-mediated genome editing of Schistosoma mansoni acetylcholinesterase
H You, JU Mayer, RL Johnston, H Sivakumaran, S Ranasinghe, V Rivera, ...
bioRxiv, 2020
152020
Alterations in signaling pathways that accompany spontaneous transition to malignancy in a mouse model of BRAF mutant microsatellite stable colorectal cancer
AM Kane, LJ Fennell, C Liu, J Borowsky, DM McKeone, CE Bond, ...
Neoplasia 22 (2), 120-128, 2020
132020
Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patients
LG Aoude, VF Bonazzi, S Brosda, K Patel, LT Koufariotis, H Oey, K Nones, ...
Scientific reports 10 (1), 1-11, 2020
112020
Variance explained by whole genome sequence variants in coding and regulatory genome annotations for six dairy traits
LT Koufariotis, YPP Chen, P Stothard, BJ Hayes
BMC genomics 19 (1), 1-16, 2018
112018
Radiomics Biomarkers Correlate with CD8 Expression and Predict Immune Signatures in Melanoma PatientsRadiomics Biomarkers Predict Melanoma Immune Signatures
LG Aoude, BZY Wong, VF Bonazzi, S Brosda, SB Walters, LT Koufariotis, ...
Molecular Cancer Research 19 (6), 950-956, 2021
102021
Targeting novel LSD1-dependent ACE2 demethylation domains inhibits SARS-CoV-2 replication
WJ Tu, RD McCuaig, M Melino, DJ Rawle, TT Le, K Yan, A Suhrbier, ...
Cell discovery 7 (1), 1-25, 2021
72021
Patient-derived xenograft models capture genomic heterogeneity in endometrial cancer
VF Bonazzi, O Kondrashova, D Smith, K Nones, AT Sengal, R Ju, ...
Genome medicine 14 (1), 1-19, 2022
62022
ctDNA as a biomarker of progression in oesophageal adenocarcinoma
VF Bonazzi, LG Aoude, S Brosda, JM Lonie, K Patel, JJ Bradford, ...
ESMO Open, 100452, 2022
52022
Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma
J Creaney, AM Patch, V Addala, SA Sneddon, K Nones, IM Dick, YC Lee, ...
Genome Medicine 14 (1), 1-18, 2022
42022
The system can't perform the operation now. Try again later.
Articles 1–20